See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← SAR page
XStocksXray
Market X-Ray report · 23 October 2026

Gr. Sarantis S.A. (SAR)

Athens Exchange · Greece · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 10.84
52-week range10.78 – 15.82
Return, 1 month / 3 months−11.3% / −24.7%
Return, 1 year / 3 years−16.6% / +50.9%
TrendBelow its 200-day average
RSI (14)24
Volatility (1 year)25.2%
Worst drawdown (1 year)-30.7%
Average daily value traded0.73M EUR
Dividend yield–

Market X-Ray price-based

35/ 100 · High confidence · ahead of 28% of stocks on this exchange
Trend13
Momentum15
Stability (higher is calmer)52
Liquidity78
Income–

Five-year price chart navy: price · brown: 200-day average

4.797.6610.5213.3916.252021-102023-012024-042025-072026-10

About the company

Gr. Sarantis is a Greek consumer goods company based in Athens that makes and markets personal care, cosmetic and household products. Its ranges cover skin care, hair care, baby care, sun protection and cleaning products, sold under brands familiar to shoppers in Greece and in Central and Eastern European markets. The company supplies supermarkets, pharmacies and other retailers, and also distributes selected international brands alongside its own lines.

On this site Gr. Sarantis S.A. appears as a stock on the Athens Exchange (Greece), code SAR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Gr. Sarantis S.A. (SAR) trades on the Athens Exchange in Greece. It last closed at EUR 10.84 on 23 October 2026.

Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 103 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 16.6% and over the last three months it fell 24.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Gr. Sarantis S.A. (SAR)

The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange

Lens and metricValueScoreReading
Trend13 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-22.7%
From 52-week high-30.7%
Momentum15 · WeakLagging most stocks on this exchange.
3-month return-24.7%
6-month return-26.7%
12-month return, skipping the last month-6.0%
Stability (higher is calmer)52 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)25.2%
Worst drawdown, 1 year (smaller is calmer)-30.7%
Liquidity78 · StrongTrades actively.
Average daily value traded0.73M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends2

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−3.7%
1 month−11.3%
3 months−24.7%
6 months−26.7%
1 year−16.6%
3 years+50.9%
5 years+35.3%

Signals

50-day / 200-day average12.52 / 14.02
Golden / death cross (60 days)Death, 27 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.24

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 0 neutral · 11 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

Recent dividends

Ex-dividend dateAmount per share
9 May 2023EUR 0.1495
3 Jun 2022EUR 0.1493
25 May 2021EUR 0.2239
11 May 2020EUR 0.1670
24 Jul 2019EUR 0.1489

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026